These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30064991)

  • 41. Effect of granulocyte and granulocyte macrophage colony stimulating factors (G-CSF and GM-CSF) on neonatal neutrophil functions.
    Wolach B; Gavrieli R; Pomeranz A
    Pediatr Res; 2000 Sep; 48(3):369-73. PubMed ID: 10960505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation.
    De Witte T; Gratwohl A; Van Der Lely N; Bacigalupo A; Stern AC; Speck B; Schattenberg A; Nissen C; Gluckman E; Fibbe WE
    Blood; 1992 Mar; 79(5):1359-65. PubMed ID: 1536959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's disease.
    Klingemann HG; Wilkie-Boyd K; Rubin A; Onetto N; Nantel SH; Barnett MJ; Reece DE; Shepherd JD; Phillips GL
    Biotechnol Ther; 1994; 5(1-2):1-13. PubMed ID: 7703829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trial.
    Khwaja A; Linch DC; Goldstone AH; Chopra R; Marcus RE; Wimperis JZ; Russell NH; Haynes AP; Milligan DW; Leyland MJ
    Br J Haematol; 1992 Oct; 82(2):317-23. PubMed ID: 1419813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
    Stone RM; Berg DT; George SL; Dodge RK; Paciucci PA; Schulman P; Lee EJ; Moore JO; Powell BL; Schiffer CA
    N Engl J Med; 1995 Jun; 332(25):1671-7. PubMed ID: 7760868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis.
    Badaró R; Nascimento C; Carvalho JS; Badaró F; Russo D; Ho JL; Reed SG; Johnson WD; Jones TC
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S23-8. PubMed ID: 7875148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo.
    Kedzierska K; Mak J; Mijch A; Cooke I; Rainbird M; Roberts S; Paukovics G; Jolley D; Lopez A; Crowe SM
    J Infect Dis; 2000 Jan; 181(1):390-4. PubMed ID: 10608795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?
    Perry SE; Mostafa SM; Wenstone R; Shenkin A; McLaughlin PJ
    Intensive Care Med; 2003 Aug; 29(8):1245-52. PubMed ID: 12774155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial.
    Powles R; Smith C; Milan S; Treleaven J; Millar J; McElwain T; Gordon-Smith E; Milliken S; Tiley C
    Lancet; 1990 Dec; 336(8728):1417-20. PubMed ID: 1978880
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Lachmann G; Kurth J; von Haefen C; Yuerek F; Wernecke KD; Spies C
    Int J Med Sci; 2017; 14(4):367-375. PubMed ID: 28553169
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of granulocyte colony-stimulating factor treatment on ex vivo neutrophil functions in nonneutropenic surgical intensive care patients.
    Gerber A; Struy H; Weiss G; Lippert H; Ansorge S; Schulz HU
    J Interferon Cytokine Res; 2000 Dec; 20(12):1083-90. PubMed ID: 11152575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma.
    Chachoua A; Oratz R; Liebes L; Alter RS; Felice A; Peace D; Vilcek J; Blum RH
    J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):132-41. PubMed ID: 7804528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.
    Uchida K; Beck DC; Yamamoto T; Berclaz PY; Abe S; Staudt MK; Carey BC; Filippi MD; Wert SE; Denson LA; Puchalski JT; Hauck DM; Trapnell BC
    N Engl J Med; 2007 Feb; 356(6):567-79. PubMed ID: 17287477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ; Hartong SC; Egeland T; Thomas GR; Eaton DL; Wagemaker G
    Blood; 1997 Oct; 90(7):2565-73. PubMed ID: 9326222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates.
    Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Tzimouli V; Taparkou A; Kremenopoulos G; Germenis A
    Cytokine; 2002 Jun; 18(5):260-5. PubMed ID: 12161101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.
    Vellenga E; Uyl-de Groot CA; de Wit R; Keizer HJ; Löwenberg B; ten Haaft MA; de Witte TJ; Verhagen CA; Stoter GJ; Rutten FF; Mulder NH; Smid WM; de Vries EG
    J Clin Oncol; 1996 Feb; 14(2):619-27. PubMed ID: 8636779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas].
    Gorin NC; Coiffier B; Hayat M; Fouillard L; Kuentz M; Flesch M; Colombat P; Boivin P; Slavin S; Lemarié JC
    Presse Med; 1993 Jan; 22(3):109-20. PubMed ID: 8493215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.